OTS-412

· Bionoxx Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OTS-412, covering 2026-04-07 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea) [Phase 1]

See pricing